deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01944293

Ketamine for Suicidality in Bipolar Depression

Ketamine vs. Midazolam in Bipolar Depression

Sponsor: Brain & Behavior Research Foundation

Conditions Bipolar Disorder Major Depressive Episode Suicidal Ideation
Interventions Ketamine Midazolam
Updated 11 times since 2017 Last updated: Feb 27, 2020 Started: Sep 30, 2013 Primary completion: Sep 30, 2017 Completion: Oct 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01944293, this PHASE1/PHASE2 trial focuses on Bipolar Disorder and Major Depressive Episode and remains completed. Sponsored by Brain & Behavior Research Foundation, it has been updated 11 times since 2013, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshotActive Not Recruiting~Mar 2019 – ~Jul 2019 · 4 months · monthly snapshotUnknown Status~Jul 2019 – ~Apr 2020 · 9 months · monthly snapshotCompleted~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE1_PHASE2

▶ Show 6 earlier versions

  1. Apr 2020 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  2. Jul 2019 — Apr 2020 [monthly]

    Completed PHASE1_PHASE2

    Status: Unknown Status → Completed

  3. Mar 2019 — Jul 2019 [monthly]

    Unknown Status PHASE1_PHASE2

    Status: Active Not Recruiting → Unknown Status

  4. Jun 2018 — Mar 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting

  6. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Brain & Behavior Research Foundation
  • New York State Psychiatric Institute
Data source: New York State Psychiatric Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations